“…The outgrowth of lesioned CST axons can be promoted by application of neurotrophic growth factors, such as vascular endothelial growth factor (VEGF) (Facchiano et al, 2002), brain-derived neurotrophic factor (BDNF) (Vavrek et al, 2006), or by knockout or neutralization of inhibitory signals such as Nogo (Schwab, 2004) and Nogo receptors (GrandPre et al, 2002). Following ischemic lesions, the adult CNS can induce cellular responses needed for neurite growth and synaptic formation (Cramer and Chopp, 2000), including the expression of growth-promoting factors, such as BDNF (Comelli et al, 1993) and basic fibroblast growth factor (bFGF) (Lin et al, 1997) that could lead to partial spontaneous functional recovery. Related studies have indicated that functional recovery in rodent ischemic stroke models is associated with collateral sprouting of the uninjured CST to the denervated side of spinal cord and is enhanced by treatment of inosine , bFGF (Kawamata et al, 1997), Nogo antibody (Papadopoulos et al, 2002) and Nogo receptor antagonist (Lee et al, 2004).…”